A study by researchers working in Brazil shows that antimicrobial photodynamic therapy in which blue light targets annatto colorant is a feasible and effective option for treatment of halitosis in mouth-breathing children.
Meitheal gains US commercial rights for CABP treatment therapy
XENLETA is intended to treat community-acquired bacterial pneumonia in the adult population. Credit: New Africa/Shutterstock. Meitheal Pharmaceuticals has gained exclusive US commercial rights for a